Assessment of osteoporosis medication adherence, quality of life, and treatment satisfaction among women with osteoporosis: A cross-sectional study

Pharmacy Practice

  • Muna Barakat1Department of Clinical Pharmacy and Therapeutics, School of Pharmacy, Applied Science Private University, Amman, Jordan.
  • Mariam ElhageDiab2School of Pharmacy, Lebanese International University, Beirut, Lebanon.
  • Bayan Othman3Department of Pharmaceutical Sciences and Pharmaceutics, Applied Science Private University, Amman, Jordan.
  • Roa’a Thaher4Family Medicine Resident, Hamad Medical Corporation, Qatar.
  • Sami El Khatib5Department of Biomedical Sciences, Lebanese International University, Bekaa, Lebanon., 6Center for Applied Mathematics and Bioinformatics (CAMB), Gulf University for Science and Technology, Kuwait.
  • Emilie Feghaly2School of Pharmacy, Lebanese International University, Beirut, Lebanon.
  • Nehmat Ghaboura7Pharmacy Practice Department, Pharmacy Program, Batterjee Medical College, P.O. Box 6231, Jeddah 21442, Saudi Arabia.
  • Mohamad Rahal2School of Pharmacy, Lebanese International University, Beirut, Lebanon.
  • Sahar Obeid8School of Arts and Sciences, Social and Education Sciences Department, Lebanese American University, Jbeil, Lebanon.
  • Souheil Hallit9School of Medicine and Medical Sciences, Holy Spirit University of Kaslik, P.O. Box 446, Jounieh, Lebanon.
  • Diana Malaeb10College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates.

Volume 24 Issue 2 Pages 1-10

DOI: 10.18549/PharmPract.2026.2.3387

Abstract

Background: Osteoporosis is considered one of the most important postmenopausal problems. The absence of efficacy markers and intolerable side effects hinders treatment outcomes. This study aimed to assess adherence to medications, quality of life and treatment satisfaction among Lebanese osteoporotic women. Methods: This cross-sectional study was conducted between March-December 2020 in community and outpatient settings distributed in all Lebanese districts. A validated questionnaire was used to gather information through face-to-face and online interviews. Data was analyzed using a statistical package for social science (SPSS). Results: A total of 72 patients were recruited with a mean age of 60.40 of ± 8.86 years. Almost all women (94.40%) were menopause with a mean age of 48.97 ± 4.78 years (mean ± SD). The majority were married (83.30%), had 2 or more children (81.90%), and were educated (86.10%). The adherence score was positively and significantly associated with the duration of smoking (beta=0.22, CI=0.03-0.41, P-value=0.027) and calcium intake (beta=5.68, CI=1.56 - 9.80, p-value=0.009). On the other hand, a negative association was noted with vitamin D intake (beta=-15.34, CI=-27.95, -2.73, p-value=0.019). Conclusion: Treatment satisfaction was significantly associated with the participant’s age and menopause status. Proper education and awareness campaigns can help young women prevent the development of osteoporosis.

Keywords

  • Osteoporosis
  • Adherence
  • Quality of life
  • Medication-use
  • Lebanon
Pharmacy Practice

Loading…